Skip to main content

Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules

Salt Lake City, UT, July 31, 2026 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on July 27, 2026, the Compensation Committee of Recursion’s Board of Directors approved the grant of inducement restricted stock unit (RSU) awards covering 3,234,866 shares of its class A common stock in the aggregate to 24 new employees under Recursion’s 2024 Inducement Equity Incentive Plan (the “2024 Plan”). Each award was granted as an inducement material to the employee’s commencement of employment with Recursion, or a subsidiary of Recursion, pursuant to Nasdaq Listing Rule 5635(c)(4). Each inducement RSU award will vest as to 1/4th of the shares subject to the award on the first quarterly vesting date on or following the one-year...

Continue reading

Core AI Holdings Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Compliance Deficiency

Miami, FL, July 31, 2026 (GLOBE NEWSWIRE) — Core AI Holdings, Inc. (“Core AI” or the “Company”) (NASDAQ: CHAI), a global AI technology and infrastructure company, today announced that today on July 31, 2026, the Company received a notification letter (“Nasdaq Notification”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement for its common shares listed on Nasdaq from June 17, 2026 through July 30, 2026. As set forth in the Nasdaq Listing Rule 5450(a)(1) (“Nasdaq Listing Rule”), the Company’s common shares listed for trading on the Nasdaq must maintain a minimum closing bid price of $1.00 per share and failure to meet it for 30 consecutive trading days constitutes a compliance deficiency. The notification has...

Continue reading

CPS Technologies Schedules Its Q2 Earnings Call

NORTON, Mass., July 31, 2026 (GLOBE NEWSWIRE) — CPS Technologies Corp. (Nasdaq:CPSH) today released instructions for its second quarter 2026 investor conference call which will be held on Wednesday August 5, 2026 at 9:00 A.M. (Eastern). Brian Mackey, President and CEO and Chris Fraser, Chief Financial Officer will discuss the Company’s financial results for the quarter ended June 27, 2026. Those interested in participating in the conference call should dial: 1-844-943-2942Participant Passcode: 255505 About CPS CPS is an advanced materials company that designs, manufactures, and sells high-performance material solutions to global customers in transportation, energy, automotive, electronics, telecommunications, aerospace, and defense. The company specializes in proprietary metal matrix composites (MMCs), combining metals and ceramics...

Continue reading

Temporary shut-down for corrective maintenance at PX Energy

THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES OR UNITED STATES PERSONS CALGARY, Alberta, July 31, 2026 (GLOBE NEWSWIRE) — Questerre Energy Corporation (“Questerre” or the “Company”) (OSE, TSX: QEC) today announced that its PX Energy oil shale processing facility in southern Brazil has been temporarily shut down for emergency corrective maintenance. This follows a critical pipe failure in the furnace that supplies heat to the main processing facility. Operations personnel initiated the shutdown promptly to limit any further impact to equipment. No injuries resulted from the incident and no damage was sustained to the main processing facility. The shutdown is currently estimated to last approximately three to four weeks. During this time, the facility...

Continue reading

Entera Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference

TEL AVIV, July 31, 2026 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, Miranda Toledano, will be participating in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference, details as below. Canaccord Genuity 46th Annual Growth Conference (Fireside Chat and 1×1 Meetings) Date and Time: August 12, 2026 at 1:00 p.m. Eastern TimeLocation: In person, August 11–13, 2026, InterContinental Boston Hotel, 510 Atlantic Avenue, Boston, MAWebcast: https://event.summitcast.com/view/WuFmFdTcA9mVsUGHZJFU62/3r4fss8AzFCZNhJDzPz9Sa A live webcast of the discussion, including presentation slides, will be available at the link above. A replay will remain accessible for 365 days following the event. About...

Continue reading

SalesCloser Secures a Top-Five Global Social Media Platform as Enterprise Customer, Deploying AI-Powered Voice Qualification at Scale

Deployment applies SalesCloser’s autonomous AI sales agents to high-volume applicant qualification for one of the top-five global social media platforms, automating the manual screening burden and integrating directly into the customer’s workflow systems Vancouver, BC, July 31, 2026 (GLOBE NEWSWIRE) — SalesCloser Technologies Ltd. (“SalesCloser” or the “Company”) (TSXV: SCAI) (OTCQB: SCTLF) (FSE: MJ5), a pioneer in autonomous AI sales technology, is pleased to announce that it has been engaged by a regional division of one of the world’s top-five social media platforms (the “Customer”),1 to deploy SalesCloser’s conversational AI platform to power applicant qualification for one of the Customer’s high-volume onboarding programs. The Customer’s onboarding program is a selective initiative through which the Customer recruits, qualifies,...

Continue reading

Cannabix Technologies Annual General Meeting Results

VANCOUVER, British Columbia, July 31, 2026 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) announces the results of its annual general meeting of common shareholders held on July 27, 2026 in Vancouver. Resolutions passed at the meeting included the appointment of SHIM and Associates LLP as auditors for the ensuing year, and the election of five directors: Dr. Raj Attariwala, Dr. Phillip Olla, Ravinder Mlait, Bryan Loree, and William Corl. We seek Safe Harbor. On behalf of the Board of Directors “Rav Mlait” CEOCannabix Technologies Inc. For further information, contact the Company at info@cannabixtechnologies.com

Continue reading

Epsilon Energy Ltd. Schedules Second Quarter 2026 Earnings Release and Conference Call

HOUSTON, July 31, 2026 (GLOBE NEWSWIRE) — Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today announced that it will issue its second quarter 2026 earnings release on Wednesday, August 12, 2026 after the market close and host a conference call to discuss its financial and operating results on Thursday, August 13, 2026 at 10:00 a.m. Central Time (11:00 a.m. Eastern Time). Interested parties in the United States and Canada may participate toll-free by dialing (833) 816-1385. International parties may participate by dialing (412) 317-0478. Participants should ask to be joined to the “Epsilon Energy First Quarter 2026 Earnings Conference Call.” A webcast can be viewed at: https://event.choruscall.com/mediaframe/webcast.html?webcastid=6qJpqYfZ. A webcast replay will be available on the Company’s website (www.epsilonenergyltd.com)...

Continue reading

FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease

Pluvicto now approved across PSMA+ metastatic prostate cancer, nearly doubling eligible patient populationPSMAddition updated results show Pluvicto reduced risk of progression or death by 33% in combination with standard of care (ADT + ARPI) vs. SoC alone, with positive overall survival trend (HR=0.80)mHSPC is incurable and about half of men progress within 20 months, highlighting need for differentiated, precision approaches earlier in disease journeyWith five US RLT manufacturing sites operational or under construction, Novartis has scale and infrastructure to meet growing demandBasel, July 31, 2026 – Novartis today announced the US Food and Drug Administration (FDA) approved Pluvicto® (lutetium Lu 177 vipivotide tetraxetan) in combination with an androgen receptor pathway inhibitor (ARPI) for patients with prostate-specific...

Continue reading

Credicorp Ltd.: Credicorp’s Earnings Release and Conference Call 2Q26

Lima, July 31, 2026 (GLOBE NEWSWIRE) — Lima, Peru, July 31, 2026 – Credicorp Ltd. announces to its shareholders and the market that its 2Q26 Earnings Release will be published on Thursday, August 13, 2026, after market close. Credicorp’s webcast and conference call to discuss these results will be held on Friday, August 16, 2026, at 9:30 a.m. Lima, Peru time and 10:30 a.m. Eastern Time. The call will be hosted by the following Credicorp executivesGianfranco Ferrari, Chief Executive Officer Alejandro Perez Reyes, Chief Financial Officer Francesca Raffo, Chief Innovation Officer Cesar Rios, Chief Risk Officer Diego Cavero, Head of Universal Banking Eduardo Montero, Head of Insurance and Pensions Rocio Benavides, Mibanco CFO Investor Relations TeamParticipants are encouraged to pre-register for the listen-only webcast at the following...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.